1064 related articles for article (PubMed ID: 18506737)
21. Neuroendocrine tumors of pancreas: how can we apply the 2006 TNM proposal?
Mboti FB; Loi P; Nagy N; Myriam D; Gelin M; Closset J
Hepatogastroenterology; 2010; 57(98):344-8. PubMed ID: 20583440
[TBL] [Abstract][Full Text] [Related]
22. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
[TBL] [Abstract][Full Text] [Related]
23. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.
Martin JA; Warner RR; Wisnivesky JP; Kim MK
Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622
[TBL] [Abstract][Full Text] [Related]
24. Parotid cancer: Impact of changes from the 1997 to the 2002 American Joint Committee on Cancer classification on outcome prediction.
Schroeder U; Groppe D; Mueller RP; Guntinas-Lichius O
Cancer; 2008 Aug; 113(4):758-64. PubMed ID: 18613074
[TBL] [Abstract][Full Text] [Related]
25. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas.
Nguyen TV; Yueh B
Cancer; 2002 Aug; 95(3):553-62. PubMed ID: 12209747
[TBL] [Abstract][Full Text] [Related]
26. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment.
Dabrowski A; Skoczylas T; Ciechański A; Wallner G; Zinkiewicz K; Cwik G; Górczyński R; Borowski A
Med Sci Monit; 2006 Oct; 12(10):CR409-15. PubMed ID: 17006399
[TBL] [Abstract][Full Text] [Related]
27. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?
Ferrone CR; Tang LH; Tomlinson J; Gonen M; Hochwald SN; Brennan MF; Klimstra DS; Allen PJ
J Clin Oncol; 2007 Dec; 25(35):5609-15. PubMed ID: 18065733
[TBL] [Abstract][Full Text] [Related]
28. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors.
Strosberg JR; Cheema A; Weber J; Han G; Coppola D; Kvols LK
J Clin Oncol; 2011 Aug; 29(22):3044-9. PubMed ID: 21709192
[TBL] [Abstract][Full Text] [Related]
29. The Chinese classification system compared with TNM staging in prognosis of patients with primary hepatic carcinoma after resection.
Sheng JM; Zhao WH; Wu FS; Ma ZM; Feng YZ; Zhou XR; Teng LS
Hepatobiliary Pancreat Dis Int; 2005 Nov; 4(4):561-4. PubMed ID: 16286262
[TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].
Zhu XZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jan; 16(1):12-4. PubMed ID: 23691561
[TBL] [Abstract][Full Text] [Related]
31. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution.
Massironi S; Rossi RE; Casazza G; Conte D; Ciafardini C; Galeazzi M; Peracchi M
Neuroendocrinology; 2014; 100(2-3):240-9. PubMed ID: 25428270
[TBL] [Abstract][Full Text] [Related]
32. Survival prognostic factors of gastro-enteric-pancreatic neuroendocrine tumors after primary tumor resection in a single tertiary center: Comparison of gastro-enteric and pancreatic locations.
Russolillo N; Vigano' L; Razzore P; Langella S; Motta M; Bertuzzo F; Papotti M; Ferrero A
Eur J Surg Oncol; 2015 Jun; 41(6):751-7. PubMed ID: 25887286
[TBL] [Abstract][Full Text] [Related]
33. [Classification of neuroendocrine tumors and the effect on surgical technique].
Schürmann G; Brüwer M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():359-61. PubMed ID: 9931641
[TBL] [Abstract][Full Text] [Related]
34. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
[TBL] [Abstract][Full Text] [Related]
35. [The new classification of neuroendocrine tumors from the clinical viewpoint].
Schürmann G; Senninger H
Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
[No Abstract] [Full Text] [Related]
36. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors.
Özaslan E; Demir S; Karaca H; Güven K
Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):836-41. PubMed ID: 26945127
[TBL] [Abstract][Full Text] [Related]
39. TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.
Berković M; Cacev T; Zjacić-Rotkvić V; Kapitanović S
Neuroendocrinology; 2006; 84(5):346-52. PubMed ID: 17164537
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
